Cerebrovascular Disorders clinical trials

The registry lists 449 studies for Cerebrovascular Disorders across more than 10 countries. 127 are recruiting or about to start. 97 of them are mainly about Cerebrovascular Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 39 narrower conditions too, such as Stroke: 13,378 studies, 3,742 open.

Get an email when these change. Save the Cerebrovascular Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 193
Recruiting: 94
Status unknown: 66
Terminated: 25
Active, not recruiting: 24
Not yet recruiting: 23

Phase

Phase 2: 43
Phase 3: 41
Phase 4: 22
Phase 1: 11
Early Phase 1: 4

Where

United States: 98
China: 83
France: 32
Canada: 24
Germany: 24
Italy: 21

Who runs them

National Heart, Lung, and Blood Institute (NHLBI) (14) · Beijing Tiantan Hospital (12) · Assistance Publique - Hôpitaux de Paris (9) · National Institute of Neurological Disorders and Stroke (NINDS) (8) · Xuanwu Hospital, Beijing (7) · Chang Gung Memorial Hospital (5) · University of Wisconsin, Madison (5) · University of Oxford (4)

What is being tested here

Drugs under test in Cerebrovascular Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Tenecteplase	1	2	4
Aspirin	1	2	4
Semaglutide	1	0	1
Tegoprazan	1	1	1
Nitric Oxide	1	0	1
Metformin	1	0	1
Nicotinamide-beta-riboside	1	0	1
Ginkgo biloba extract	1	0	1
Vitamin E	0	1	3
Ascorbic Acid	0	0	2

Drug classes tested here NSAIDs 1 open · Thrombolytics 1 open · Statins 3

Coming up

10phase 3 studies under way

40studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Jun 2027Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) · Phase 3 · Hanyang University Guri Hospital
Aug 2027Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke · Phase 3 · University of Melbourne
Nov 2026BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS · Hospital Alemão Oswaldo Cruz
Nov 2026Assess the Risk of Cerebrovascular Disease · Tang-Du Hospital
Nov 2026Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders · Research Center of Neurology, Russia
Nov 2026Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use. · Leica Microsystems (Schweiz) AG
Nov 2026Clinical Application of a Low-Dose CBCT AI Model · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Nov 2026International Intracranial Dissection Study · Insel Gruppe AG, University Hospital Bern
Dec 2026Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · Johns Hopkins University
Dec 2026Rajavithi Health Promotion Project (Population Base Cohort) · Rajavithi Hospital

Who these studies take

Of the 94 Cerebrovascular Disorders studies recruiting now, 54 (57%) set no upper age limit and 12 (13%) stop at 75 or younger. 9 (10%) take children under 18. 1 (1%) are for women only and 0 (0%) for men only; 19 (20%) take healthy volunteers.

Recruiting studies that take each age, of 94
Age	Women	Men
10	8 (9%)	8 (9%)
18	75 (80%)	75 (80%)
30	81 (86%)	80 (85%)
40	85 (90%)	84 (89%)
50	90 (96%)	89 (95%)
65	89 (95%)	88 (94%)
75	86 (91%)	86 (91%)
85	66 (70%)	66 (70%)

Across all 449 studies, recruiting or not: 13% stop at 75 or younger and 7% at 65; 10% take children; 1% are for women only and 2% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cerebrovascular Disorders studies take

Of 111 interventional studies with no phase under Cerebrovascular Disorders, half reached primary completion within 30 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	30 mo14–68 · 111 studies	—	30 mo14–68 · 96 studies
Observational	103 mo46–339 · 79 studies	—	103 mo59–339 · 75 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB DeviceNov 10, 2026NCT04839705

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 449. Browse all 449 → or search them.